- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Dasatinib – March 2019
Dasatinib: Tablet 20 mg, Tablet 50 mg, Tablet 70 mg, Tablet 100 mg; Sprycel®
Last updated
5 July 2019